Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma

Table 1 Clinicopathological features of the colon adenocarcinoma patients in two databases, n (%)

	TCGA-COAD	GSE39582
Number of patients	385	566
Survival status
Alive	306 (79.5)	371 (65.5)
Dead	79 (20.5)	191 (33.7)
Unknown		4 (0.8)
Survival time in d
Range for OS days	0-4502	0-2412
OS days, median	670	612
Age in yr	67.00 ± 12.76	66.87 ± 13.28
Range	31-90	22-97
Median	69	68
Sex
Female	180 (46.7)	256 (45.2)
Male	205 (53.2)	310 (54.8)
Stage
I	66 (17.1)	33 (5.8)
II	151 (39.2)	264 (46.6)
III	103 (26.8)	205 (36.2)
IV	54 (14.0)	60 (10.6)

TCGA-COAD: The Cancer Genome Atlas database-colon adenocarcinoma; OS: Overall survival.